Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets

Researchers have uncovered a new way to potentially halt pulmonary fibrosis, a severe condition where lung tissue becomes damaged and scarred. To do this, scientists mapped out the immunopeptidome in both humans and mice suffering from the disease. The immunopeptidome refers to the collection of tiny protein fragments, or peptides, that cells display on their surface. These fragments act like molecular name tags, telling the immune system whether a cell is healthy, infected, or damaged.

By examining the specific name tags displayed by MHC class I molecules, which are the primary proteins that present these fragments to the immune system, the team found unique peptides that only appear on cells involved in lung scarring. These specific fragments are immunogenic, meaning they can actively trigger an immune response. When the researchers targeted these specific peptides in mice with drug-induced lung scarring, they successfully blocked the disease from progressing.